On the public citation graph

Effect of incorporation of cidofovir into DNA by human cytomegalovirus DNA polymerase on DNA elongation

0 signed · 189 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1016/0006-2952(91)90276-bopenalex-snapshot
Broad-spectrum anti-DNA virus and anti-retrovirus activity of phosphonylmethoxyalkylpurines and -pyrimidines
inferredcites →https://doi.org/10.1016/0006-2952(94)90600-9openalex-snapshot
Kinetic analysis of the interaction between the diphosphate of (S)-1-(3-hydroxy-2-phosphonylemthoxypropyl)cytosine, ddCTP, AZTTP, and FIAUTP with human DNA polymerases β and γ
inferredcites →https://doi.org/10.1016/0006-2952(96)00100-1openalex-snapshot
Kinetic analysis of the interaction of cidofovir diphosphate with human cytomegalovirus DNA polymerase
inferredcites →https://doi.org/10.1016/0167-4781(82)90018-5openalex-snapshot
Pyrophosphate analogues as inhibitors of DNA polymerases of cytomegalovirus, herpes simplex virus and cellular origin
inferredcites →https://doi.org/10.1016/s0021-9258(17)43446-6openalex-snapshot
Interaction of herpes simplex virus-induced DNA polymerase with 9-(1,3-dihydroxy-2-propoxymethyl)guanine triphosphate.
inferredcites →https://doi.org/10.1016/s0021-9258(18)48487-6openalex-snapshot
Metabolism of 4'-azidothymidine. A compound with potent and selective activity against the human immunodeficiency virus.
inferredcites →https://doi.org/10.1016/s0021-9258(18)69010-6openalex-snapshot
Insertion and extension of acyclic, dideoxy, and ara nucleotides by herpesviridae, human alpha and human beta polymerases. A unique inhibition mechanism for 9-(1,3-dihydroxy-2-propoxymethyl)guanine triphosphate.
inferredcites →https://doi.org/10.1016/s0021-9258(19)36631-1openalex-snapshot
Human DNA polymerases alpha and beta are able to incorporate anti-HIV deoxynucleotides into DNA.
inferredcites →https://doi.org/10.1016/s0021-9258(19)47263-3openalex-snapshot
Herpes simplex virus type 1 and human DNA polymerase interactions with 2′-deoxyguanosine 5′-triphosphate analogues
inferredcites →https://doi.org/10.1016/s0021-9258(19)86585-7openalex-snapshot
Kinetic studies of herpes simplex virus type 1-encoded thymidine and thymidylate kinase, a multifunctional enzyme.
inferredcites →https://doi.org/10.1021/bi00074a011openalex-snapshot
Selective action of 4'-azidothymidine triphosphate on reverse transcriptase of human immunodeficiency virus type 1 and human DNA polymerases .alpha. and .beta.
inferredcites →https://doi.org/10.1073/pnas.82.8.2473openalex-snapshot
Metabolic activation of the nucleoside analog 9-[( 2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine in human diploid fibroblasts infected with human cytomegalovirus.
inferredcites →https://doi.org/10.1128/aac.28.2.240openalex-snapshot
Activity of 9-(1,3-dihydroxy-2-propoxymethyl)guanine compared with that of acyclovir against human, monkey, and rodent cytomegaloviruses
inferredcites →https://doi.org/10.1128/jvi.56.3.846-851.1985openalex-snapshot
Human cytomegalovirus-induced DNA polymerase and its interaction with the triphosphates of 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-methyluracil, -5-iodocytosine, and -5-methylcytosine
inferredcites →https://doi.org/10.1128/jvi.68.7.4427-4431.1994openalex-snapshot
Mutation in the UL97 open reading frame of human cytomegalovirus strains resistant to ganciclovir

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.1016/j.phytochem.2021.112842zenodo-depositor-declared
Unusual matrine–adenine hybrids isolated from Sophora davidii and their inhibitory effects on human cytomegalovirus
inferred← citeshttps://doi.org/10.1001/archderm.136.8.983openalex-snapshot
Topical Cidofovir
inferred← citeshttps://doi.org/10.1002/(sici)1099-1654(199709)7:3<145::aid-rmv196>3.0.co;2-0openalex-snapshot
Clinical uses of cidofovir
inferred← citeshttps://doi.org/10.1002/0471266949.bmc083openalex-snapshot
Antiviral Agents, RNA Viruses (Other than HIV), and Orthopoxviruses
inferred← citeshttps://doi.org/10.1002/1097-0215(200102)9999:9999<::aid-ijc1183>3.0.co;2-kopenalex-snapshot
Potent inhibition of hemangiosarcoma development in mice by cidofovir
inferred← citeshttps://doi.org/10.1002/9780470571224.pse026openalex-snapshot
Strategies in the Design of Antiviral Drugs
inferred← citeshttps://doi.org/10.1002/9781683670438.mcm0114openalex-snapshot
Antiviral Agents
inferred← citeshttps://doi.org/10.1002/9781683674849.mcm0114openalex-snapshot
Antiviral Agents
inferred← citeshttps://doi.org/10.1002/9783527635955.ch10openalex-snapshot
Anti‐HCMV Compounds
inferred← citeshttps://doi.org/10.1002/9783527635955.ch5openalex-snapshot
Acyclic and Cyclic Nucleoside Phosphonates
inferred← citeshttps://doi.org/10.1002/9783527845088.ch15openalex-snapshot
Discovery and Development of Brincidofovir
inferred← citeshttps://doi.org/10.1002/ajoc.202200652openalex-snapshot
A new entrant in ketene family: Generation of 2‐(3‐Oxo‐allyl)‐isoindole‐1,3‐dione and their [4+2] Cycloadditions with 1,3‐Diazabuta‐1,3‐dienes
inferred← citeshttps://doi.org/10.1002/ange.200603435openalex-snapshot
Enzymatic Synthesis of Phosphonomethyl Oligonucleotides by Therminator Polymerase
inferred← citeshttps://doi.org/10.1002/anie.200603435openalex-snapshot
Enzymatic Synthesis of Phosphonomethyl Oligonucleotides by Therminator Polymerase
inferred← citeshttps://doi.org/10.1002/bmc.5061openalex-snapshot
A quantitative LC–MS/MS method for the determination of tissue brincidofovir and cidofovir diphosphate in a MuPyV‐infected mouse model
inferred← citeshttps://doi.org/10.1002/jhet.2773openalex-snapshot
A Facile and Chemoselective Synthesis of Novel Pyrimido[5,4‐b][1,4]thiazines by exo‐dig Iodocyclization Reactions
inferred← citeshttps://doi.org/10.1002/jmv.20150openalex-snapshot
Cytomegalovirus antiviral resistance associated with treatment induced UL97 (protein kinase) and UL54 (DNA polymerase) mutations
inferred← citeshttps://doi.org/10.1002/med.20128openalex-snapshot
The discovery of antiviral agents: Ten different compounds, ten different stories
inferred← citeshttps://doi.org/10.1002/rmv.1740openalex-snapshot
Glycoprotein targeted therapeutics: a new era of anti‐herpes simplex virus‐1 therapeutics
inferred← citeshttps://doi.org/10.1002/rmv.2220openalex-snapshot
Antivirals against human polyomaviruses: Leaving no stone unturned
inferred← citeshttps://doi.org/10.1002/rmv.439openalex-snapshot
Therapeutic potential of nucleoside/nucleotide analogues against poxvirus infections
inferred← citeshttps://doi.org/10.1002/zaac.201300095openalex-snapshot
Extent of Intramolecular π Stacks in Aqueous Solution in Mixed‐Ligand Copper(II) Complexes Formed by Heteroaromatic Amines and 1‐[2‐(Phosphonomethoxy)ethyl]cytosine (PMEC), a Relative of Antivirally Active Acyclic Nucleotide Analogues (Part 72)[1, 2]
inferred← citeshttps://doi.org/10.1006/viro.1998.9299openalex-snapshot
A Point Mutation in the Human Cytomegalovirus DNA Polymerase Gene Selectedin Vitroby Cidofovir Confers a Slow Replication Phenotype in Cell Culture
inferred← citeshttps://doi.org/10.1007/978-0-387-31047-3_10openalex-snapshot
Selective inhibitors of the replication of poxviruses
inferred← citeshttps://doi.org/10.1007/978-1-4615-4743-3_10openalex-snapshot
Cidofovir
inferred← citeshttps://doi.org/10.1007/978-1-4939-0667-3_7-1openalex-snapshot
Antiviral Drug Resistance in Herpesviruses
inferred← citeshttps://doi.org/10.1007/978-1-4939-0694-9_7openalex-snapshot
Antiviral Drug Resistance in Herpesviruses
inferred← citeshttps://doi.org/10.1007/978-3-030-68321-4_4openalex-snapshot
Mechanisms of Nonretroviral Resistance
inferred← citeshttps://doi.org/10.1007/978-3-031-57165-7_12openalex-snapshot
Poxviridae Pneumonia
inferred← citeshttps://doi.org/10.1007/978-3-031-57369-9_18openalex-snapshot
Antiviral Agents: Cidofovir and Brincidofovir
inferred← citeshttps://doi.org/10.1007/978-3-319-66884-0_41openalex-snapshot
Systemic Antivirals in Dermatology
inferred← citeshttps://doi.org/10.1007/978-3-540-79086-0_3openalex-snapshot
Antiviral Agents Acting as DNA or RNA Chain Terminators
inferred← citeshttps://doi.org/10.1007/978-94-017-9257-8_4openalex-snapshot
DNA Dependent DNA Polymerases as Targets for Low-Weight Molecular Inhibitors: State of Art and Prospects of Rational Design
inferred← citeshttps://doi.org/10.1007/978-981-16-0267-2_1openalex-snapshot
Antiviral Drugs Against Herpesviruses
inferred← citeshttps://doi.org/10.1007/b135974_22openalex-snapshot
Viral DNA Polymerase Inhibitors
inferred← citeshttps://doi.org/10.1007/s11427-020-1752-1openalex-snapshot
Translation of the long-term fundamental studies on viral DNA packaging motors into nanotechnology and nanomedicine
inferred← citeshttps://doi.org/10.1016/b0-08-045044-x/00212-1openalex-snapshot
Deoxyribonucleic Acid Viruses: Antivirals for Herpesviruses and Hepatitis B Virus
inferred← citeshttps://doi.org/10.1016/b978-0-12-405880-4.00004-4openalex-snapshot
Advances in the Treatment of Varicella-Zoster Virus Infections
inferred← citeshttps://doi.org/10.1016/b978-0-12-815422-9.00004-8openalex-snapshot
DNA-Dependent DNA Polymerases as Drug Targets in Herpesviruses and Poxviruses
inferred← citeshttps://doi.org/10.1016/b978-0-12-815422-9.00012-7openalex-snapshot
Herpesvirus Polymerase Inhibitors
inferred← citeshttps://doi.org/10.1016/bs.enz.2021.07.003openalex-snapshot
DNA polymerases of herpesviruses and their inhibitors
inferred← citeshttps://doi.org/10.1016/j.antiviral.2007.08.009openalex-snapshot
Hydroxyurea enhances the activity of acyclovir and cidofovir against herpes simplex virus type 1 resistant strains harboring mutations in the thymidine kinase and/or the DNA polymerase genes
inferred← citeshttps://doi.org/10.1016/j.antiviral.2009.01.005openalex-snapshot
Alkoxyalkyl prodrugs of acyclic nucleoside phosphonates enhance oral antiviral activity and reduce toxicity: Current state of the art
inferred← citeshttps://doi.org/10.1016/j.antiviral.2009.09.012openalex-snapshot
Antiviral evaluation of octadecyloxyethyl esters of (S)-3-hydroxy-2-(phosphonomethoxy)propyl nucleosides against herpesviruses and orthopoxviruses
inferred← citeshttps://doi.org/10.1016/j.antiviral.2011.09.007openalex-snapshot
Virological failure of intralesional cidofovir therapy in recurrent respiratory papillomatosis is not associated with genetic or epigenetic changes of HPV11: Complete genome comparison of sequential isolates
inferred← citeshttps://doi.org/10.1016/j.antiviral.2012.08.010openalex-snapshot
The antiviral activity and mechanism of action of (S)-[3-hydroxy-2-(phosphonomethoxy)propyl] (HPMP) nucleosides
inferred← citeshttps://doi.org/10.1016/j.antiviral.2014.10.005openalex-snapshot
Cidofovir and brincidofovir reduce the pathology caused by systemic infection with human type 5 adenovirus in immunosuppressed Syrian hamsters, while ribavirin is largely ineffective in this model
inferred← citeshttps://doi.org/10.1016/j.antiviral.2014.10.012openalex-snapshot
Insights into the mechanism of action of cidofovir and other acyclic nucleoside phosphonates against polyoma- and papillomaviruses and non-viral induced neoplasia
inferred← citeshttps://doi.org/10.1016/j.antiviral.2015.10.010openalex-snapshot
The lipid moiety of brincidofovir is required for in vitro antiviral activity against Ebola virus
inferred← citeshttps://doi.org/10.1016/j.antiviral.2018.08.015openalex-snapshot
In vitro evaluation of current and novel antivirals in combination against human cytomegalovirus
inferred← citeshttps://doi.org/10.1016/j.antiviral.2018.09.003openalex-snapshot
New therapies for human cytomegalovirus infections
inferred← citeshttps://doi.org/10.1016/j.antiviral.2020.104872openalex-snapshot
Effect of brincidofovir on adenovirus and A549 cells transcriptome profiles
inferred← citeshttps://doi.org/10.1016/j.antiviral.2024.106057openalex-snapshot
Nucleotide analogues and mpox: Repurposing the repurposable
inferred← citeshttps://doi.org/10.1016/j.bcp.2008.08.009openalex-snapshot
Intracellular metabolism of the new antiviral compound 1-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]-5-azacytosine
inferred← citeshttps://doi.org/10.1016/j.bcp.2011.03.027openalex-snapshot
The clinical potential of the acyclic (and cyclic) nucleoside phosphonates. The magic of the phosphonate bond
inferred← citeshttps://doi.org/10.1016/j.bcp.2022.115322openalex-snapshot
Acyclovir resistance in herpes simplex viruses: Prevalence and therapeutic alternatives
inferred← citeshttps://doi.org/10.1016/j.bcp.2024.116448openalex-snapshot
Unachieved antiviral strategies with acyclic nucleoside phosphonates: Dedicated to the memory of dr. Salvatore “Sam” Joseph Enna
inferred← citeshttps://doi.org/10.1016/j.coviro.2014.06.003openalex-snapshot
Current and future therapies for herpes simplex virus infections: mechanism of action and drug resistance
inferred← citeshttps://doi.org/10.1016/j.ica.2017.06.011openalex-snapshot
Metal-ion binding properties of (S)-1-[3-hydroxy-2-(phosphonomethoxy)propyl]cytosine (HPMPC, Cidofovir). A nucleotide analogue with activity against DNA viruses
inferred← citeshttps://doi.org/10.1016/j.ijporl.2006.06.018openalex-snapshot
3.5-Year follow-up of intralesional cidofovir protocol for pediatric recurrent respiratory papillomatosis
inferred← citeshttps://doi.org/10.1016/j.ijporl.2008.04.003openalex-snapshot
Scientific and clinical aspects of the use of cidofovir in recurrent respiratory papillomatosis
inferred← citeshttps://doi.org/10.1016/j.joms.2010.10.040openalex-snapshot
Novel Treatment of Atypical Human Papillomavirus-Associated Epithelial Hyperplasia With Cidofovir
inferred← citeshttps://doi.org/10.1016/j.micres.2023.127504openalex-snapshot
Comprehensive overview of 2022 human monkeypox outbreak and its pathology, prevention, and treatment: A strategy for disease control
inferred← citeshttps://doi.org/10.1016/j.molstruc.2010.06.045openalex-snapshot
Self-assembling of dihydroxypropyl 5,6-dihydrothymine derivatives
inferred← citeshttps://doi.org/10.1016/j.oraloncology.2004.11.003openalex-snapshot
Antiviral activity of Cidofovir on a naturally human papillomavirus-16 infected squamous cell carcinoma of the head and neck (SCCHN) cell line improves radiation sensitivity
inferred← citeshttps://doi.org/10.1016/j.poly.2015.02.022openalex-snapshot
Extent of intramolecular π stacks in aqueous solution in mixed-ligand copper(II) complexes formed by heteroaromatic amines and the anticancer and antivirally active 9-[2-(phosphonomethoxy)ethyl]guanine (PMEG). A comparison with related acyclic nucleotide analogues
inferred← citeshttps://doi.org/10.1016/j.rvsc.2020.11.023openalex-snapshot
Diphenyl diselenide and cidofovir present anti-viral activity against Bovine Alphaherpesvirus 2 in vitro and in a sheep model
inferred← citeshttps://doi.org/10.1016/j.survophthal.2003.12.008openalex-snapshot
Posterior segment manifestations of HIV/AIDS
inferred← citeshttps://doi.org/10.1016/j.tiv.2014.10.005openalex-snapshot
Application of RPTEC/TERT1 cells for investigation of repeat dose nephrotoxicity: A transcriptomic study
inferred← citeshttps://doi.org/10.1016/j.virusres.2017.01.019openalex-snapshot
Herpesvirus DNA polymerases: Structures, functions and inhibitors
inferred← citeshttps://doi.org/10.1016/s0166-3542(02)00008-6openalex-snapshot
Cidofovir in the treatment of poxvirus infections
inferred← citeshttps://doi.org/10.1016/s0166-3542(02)00098-0openalex-snapshot
Sequence changes in the human adenovirus type 5 DNA polymerase associated with resistance to the broad spectrum antiviral cidofovir
inferred← citeshttps://doi.org/10.1016/s0166-3542(97)00050-8openalex-snapshot
In vitro characterization of the anti-human cytomegalovirus activity of PMEA (Adefovir)
inferred← citeshttps://doi.org/10.1016/s0166-3542(98)00051-5openalex-snapshot
Genetic analysis of a ganciclovir-resistant human cytomegalovirus mutant
inferred← citeshttps://doi.org/10.1016/s0166-6851(99)00202-9openalex-snapshot
Plasmodium falciparum clones resistant to (S)-9-(3-hydroxy-2-phosphonylmethoxy-propyl)adenine carry amino acid substitutions in DNA polymerase δ
inferred← citeshttps://doi.org/10.1016/s0190-9622(98)70046-5openalex-snapshot
Topical and intralesional cidofovir: A review of pharmacology and therapeutic effects
inferred← citeshttps://doi.org/10.1016/s0732-8893(98)00081-9openalex-snapshot
The prevalence of fluoroquinolone resistance among clinically significant respiratory tract isolates of Streptococcus pneumoniae in the United States and Canada—1997 results from the SENTRY Antimicrobial Surveillance Program
inferred← citeshttps://doi.org/10.1016/s0733-8635(02)00116-xopenalex-snapshot
Topical cidofovir for the treatment of dermatologic conditions: verruca, condyloma, intraepithelial neoplasia, herpes simplex and its potential use in smallpox
inferred← citeshttps://doi.org/10.1016/s0733-8635(05)70227-8openalex-snapshot
ANTIVIRAL AGENTS
inferred← citeshttps://doi.org/10.1016/s0924-8579(01)00411-3openalex-snapshot
Hamao Umezawa Memorial Award Lecture11Delivered by the author at the Twenty-second International Congress of Chemotherapy, Amsterdam, The Netherlands (30 June–3 July 2001).
inferred← citeshttps://doi.org/10.1016/s0924-8579(99)00003-5openalex-snapshot
Inhibition of the in vitro growth of Plasmodium falciparum by acyclic nucleoside phosphonates
inferred← citeshttps://doi.org/10.1016/s0960-894x(00)00402-9openalex-snapshot
Naphthalene carboxamides as inhibitors of human cytomegalovirus DNA polymerase
inferred← citeshttps://doi.org/10.1016/s0968-0896(99)00032-2openalex-snapshot
Indolocarbazoles: potent, selective inhibitors of human cytomegalovirus replication
inferred← citeshttps://doi.org/10.1016/s1040-0486(99)90007-8openalex-snapshot
Viral disease update
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.5c03356openalex-snapshot
1-Hydroxy-1,8-napthyridinone (DHN) Analogs Potently Inhibit Monkeypox Virus Resolvase (Mpr)
inferred← citeshttps://doi.org/10.1021/cr500255eopenalex-snapshot
Current and Potential Treatments for Ubiquitous but Neglected Herpesvirus Infections
inferred← citeshttps://doi.org/10.1021/jm061484yopenalex-snapshot
N-(3,3a,4,4a,5,5a,6,6a-Octahydro-1,3-dioxo-4,6- ethenocycloprop[f]isoindol-2-(1H)-yl)carboxamides: Identification of Novel Orthopoxvirus Egress Inhibitors
inferred← citeshttps://doi.org/10.1038/nrd1877openalex-snapshot
Acyclic nucleoside phosphonates: a key class of antiviral drugs
inferred← citeshttps://doi.org/10.1038/nrd703openalex-snapshot
Strategies in the design of antiviral drugs
inferred← citeshttps://doi.org/10.1038/s41392-022-01215-4openalex-snapshot
Monkeypox: epidemiology, pathogenesis, treatment and prevention
inferred← citeshttps://doi.org/10.1039/c4nj00813hopenalex-snapshot
Synthesis and study of (R)- and (S)-β-hydroxyphosphonate acyclonucleosides as structural analogues of (S)-HPMPC (cidofovir)
inferred← citeshttps://doi.org/10.1039/c5ra22896dopenalex-snapshot
In search for effective and definitive treatment of herpes simplex virus type 1 (HSV-1) infections
inferred← citeshttps://doi.org/10.1042/bj20070853openalex-snapshot
Characterization of the DNA- and dNTP-binding activities of the human cytomegalovirus DNA polymerase catalytic subunit UL54
inferred← citeshttps://doi.org/10.1046/j.1365-2133.2000.03769.xopenalex-snapshot
Cidofovir inhibits growth of B16 melanoma cells in vivo
inferred← citeshttps://doi.org/10.1046/j.1529-8019.2000.00028.xopenalex-snapshot
A review of antiviral therapies in the treatment of cytomegalovirus
inferred← citeshttps://doi.org/10.1067/mjd.2002.121033openalex-snapshot
Antiviral agents: Nonantiviral drugs
inferred← citeshttps://doi.org/10.1073/pnas.1405981111openalex-snapshot
Mechanism of ganciclovir-induced chain termination revealed by resistant viral polymerase mutants with reduced exonuclease activity
inferred← citeshttps://doi.org/10.1073/pnas.2618057123openalex-snapshot
Host DNA repair factors empower a mechanism of antiviral nucleoside analog resistance
inferred← citeshttps://doi.org/10.1074/jbc.m109.012500openalex-snapshot
Engineering of a Chimeric RB69 DNA Polymerase Sensitive to Drugs Targeting the Cytomegalovirus Enzyme
inferred← citeshttps://doi.org/10.1074/jbc.m109.096529openalex-snapshot
The Acyclic 2,4-Diaminopyrimidine Nucleoside Phosphonate Acts as a Purine Mimetic in HIV-1 Reverse Transcriptase DNA Polymerization
inferred← citeshttps://doi.org/10.1080/00958972.2018.1490019openalex-snapshot
Intramolecular π-stacks in mixed-ligand copper(II) complexes formed by heteroaromatic amines and antivirally active acyclic nucleotide analogs carrying a hydroxy-2-(phosphonomethoxy)propyl residue‡
inferred← citeshttps://doi.org/10.1080/13543784.2021.1881061openalex-snapshot
Targeting Ebola virus replication through pharmaceutical intervention
inferred← citeshttps://doi.org/10.1080/14656566.2024.2353627openalex-snapshot
Advances in pharmacotherapies for cytomegalovirus infection: what is the current state of play?
inferred← citeshttps://doi.org/10.1093/infdis/jiw073openalex-snapshot
Analysis of Mutations in the Gene Encoding Cytomegalovirus DNA Polymerase in a Phase 2 Clinical Trial of Brincidofovir Prophylaxis
inferred← citeshttps://doi.org/10.1093/jpids/pit048openalex-snapshot
Ganciclovir, Foscarnet, and Cidofovir: Antiviral Drugs Not Just for Cytomegalovirus
inferred← citeshttps://doi.org/10.1093/nar/gkw875openalex-snapshot
Distribution and effects of amino acid changes in drug-resistant α and β herpesviruses DNA polymerase
inferred← citeshttps://doi.org/10.1097/00005537-200407000-00004openalex-snapshot
Cidofovir Plasma Assays after Local Injection in Respiratory Papillomatosis
inferred← citeshttps://doi.org/10.1097/00006454-200111000-00016openalex-snapshot
Successful treatment of foscarnet-resistant herpes simplex stomatitis with intravenous cidofovir in a child
inferred← citeshttps://doi.org/10.1097/00007890-199909270-00014openalex-snapshot
NOVEL MECHANISM OF INHIBITION OF CYTOMEGALOVIRUS BY THE EXPERIMENTAL IMMUNOSUPPRESSIVE AGENT LEFLUNOMIDE1,2
inferred← citeshttps://doi.org/10.1099/0022-1317-81-3-639openalex-snapshot
Resistance of herpes simplex virus type 1 against different phosphonylmethoxyalkyl derivatives of purines and pyrimidines due to specific mutations in the viral DNA polymerase gene
inferred← citeshttps://doi.org/10.1099/vir.0.80910-0openalex-snapshot
Murine cytomegalovirus resistant to antivirals has genetic correlates with human cytomegalovirus
inferred← citeshttps://doi.org/10.1111/apm.12134openalex-snapshot
The human polyomavirus BK ( BKP yV): virological background and clinical implications
inferred← citeshttps://doi.org/10.1111/cbdd.12090openalex-snapshot
Metal‐mediated Targeting in the Body
inferred← citeshttps://doi.org/10.1111/j.1365-2133.2005.06355.xopenalex-snapshot
Successful treatment of a refractory verruca in a child with acute lymphoblastic leukaemia with topical cidofovir
inferred← citeshttps://doi.org/10.1111/j.1365-2141.2011.08988.xopenalex-snapshot
Management of multidrug‐resistant viruses in the immunocompromised host
inferred← citeshttps://doi.org/10.1111/j.1399-3062.2011.00682.xopenalex-snapshot
Leflunomide for cytomegalovirus: bench to bedside
inferred← citeshttps://doi.org/10.1128/9781555815493.ch1openalex-snapshot
Antiherpesviral DNA Polymerase Inhibitors
inferred← citeshttps://doi.org/10.1128/9781555816728.ch108openalex-snapshot
Antiviral Agents
inferred← citeshttps://doi.org/10.1128/9781555817381.ch110openalex-snapshot
Antiviral Agents
inferred← citeshttps://doi.org/10.1128/aac.00062-13openalex-snapshot
Selection and Recombinant Phenotyping of a Novel CMX001 and Cidofovir Resistance Mutation in Human Cytomegalovirus
inferred← citeshttps://doi.org/10.1128/aac.00238-15openalex-snapshot
Brincidofovir (CMX001) Inhibits BK Polyomavirus Replication in Primary Human Urothelial Cells
inferred← citeshttps://doi.org/10.1128/aac.00390-21openalex-snapshot
Impact of Amino Acid Substitutions in Region II and Helix K of Herpes Simplex Virus 1 and Human Cytomegalovirus DNA Polymerases on Resistance to Foscarnet
inferred← citeshttps://doi.org/10.1128/aac.00615-10openalex-snapshot
Resistance of Herpes Simplex Viruses to Nucleoside Analogues: Mechanisms, Prevalence, and Management
inferred← citeshttps://doi.org/10.1128/aac.01172-07openalex-snapshot
Cidofovir and ( S )-9-[3-Hydroxy-(2-Phosphonomethoxy)Propyl]Adenine Are Highly Effective Inhibitors of Vaccinia Virus DNA Polymerase When Incorporated into the Template Strand
inferred← citeshttps://doi.org/10.1128/aac.01641-20openalex-snapshot
Alkoxylalkyl Esters of Nucleotide Analogs Inhibit Polyomavirus DNA Replication and Large T Antigen Activities
inferred← citeshttps://doi.org/10.1128/aac.01809-10openalex-snapshot
Activities of Different Classes of Acyclic Nucleoside Phosphonates against BK Virus in Primary Human Renal Cells
inferred← citeshttps://doi.org/10.1128/aac.01925-18openalex-snapshot
Cidofovir Diphosphate Inhibits Adenovirus 5 DNA Polymerase via both Nonobligate Chain Termination and Direct Inhibition, and Polymerase Mutations Confer Cidofovir Resistance on Intact Virus
inferred← citeshttps://doi.org/10.1128/aac.03686-14openalex-snapshot
Human Cytomegalovirus Resistance to Deoxyribosylindole Nucleosides Maps to a Transversion Mutation in the Terminase Subunit-Encoding Gene UL89
inferred← citeshttps://doi.org/10.1128/aac.05161-11openalex-snapshot
Inhibition of HIV-1 by Octadecyloxyethyl Esters of (S)-[3-Hydroxy-2-(Phosphonomethoxy)Propyl] Nucleosides and Evaluation of Their Mechanism of Action
inferred← citeshttps://doi.org/10.1128/aac.42.5.1146openalex-snapshot
Disposition of the Acyclic Nucleoside Phosphonate ( S )-9(3-Hydroxy-2-Phosphonylmethoxypropyl)Adenine
inferred← citeshttps://doi.org/10.1128/aac.43.12.2885openalex-snapshot
Hydroxyurea Potentiates the Antiherpesvirus Activities of Purine and Pyrimidine Nucleoside and Nucleoside Phosphonate Analogs
inferred← citeshttps://doi.org/10.1128/aac.43.5.1198openalex-snapshot
Selective Inhibition of Human Papillomavirus-Induced Cell Proliferation by ( S )-1-[3-Hydroxy-2-(Phosphonylmethoxy)propyl]cytosine
inferred← citeshttps://doi.org/10.1128/aac.47.6.2022-2026.2003openalex-snapshot
Alpha Interferon Augments Cidofovir's Antiviral and Antiproliferative Activities
inferred← citeshttps://doi.org/10.1128/aac.49.12.4965-4973.2005openalex-snapshot
Potent Antiviral Activity of North-Methanocarbathymidine against Kaposi's Sarcoma-Associated Herpesvirus
inferred← citeshttps://doi.org/10.1128/aac.49.8.3153-3162.2005openalex-snapshot
Mechanism of Inhibition of Vaccinia Virus DNA Polymerase by Cidofovir Diphosphate
inferred← citeshttps://doi.org/10.1128/cmr.14.2.382-397.2001openalex-snapshot
Vaccinia Virus Inhibitors as a Paradigm for the Chemotherapy of Poxvirus Infections
inferred← citeshttps://doi.org/10.1128/cmr.16.4.569-596.2003openalex-snapshot
Clinical Potential of the Acyclic Nucleoside Phosphonates Cidofovir, Adefovir, and Tenofovir in Treatment of DNA Virus and Retrovirus Infections
inferred← citeshttps://doi.org/10.1128/jvi.01061-09openalex-snapshot
Cidofovir Inhibits Genome Encapsidation and Affects Morphogenesis during the Replication of Vaccinia Virus
inferred← citeshttps://doi.org/10.1128/jvi.72.7.5927-5936.1998openalex-snapshot
Characterization of Drug Resistance-Associated Mutations in the Human Cytomegalovirus DNA Polymerase Gene by Using Recombinant Mutant Viruses Generated from Overlapping DNA Fragments
inferred← citeshttps://doi.org/10.1128/jvi.79.20.13139-13149.2005openalex-snapshot
An Orally Bioavailable Antipoxvirus Compound (ST-246) Inhibits Extracellular Virus Formation and Protects Mice from Lethal Orthopoxvirus Challenge
inferred← citeshttps://doi.org/10.1128/jvi.80.3.1440-1450.2006openalex-snapshot
Role of Helix P of the Human Cytomegalovirus DNA Polymerase in Resistance and Hypersusceptibility to the Antiviral Drug Foscarnet
inferred← citeshttps://doi.org/10.1128/mbio.01049-24openalex-snapshot
Brincidofovir inhibits polyomavirus infection in vivo
inferred← citeshttps://doi.org/10.1128/mbio.03492-20openalex-snapshot
Resistance to a Nucleoside Analog Antiviral Drug from More Rapid Extension of Drug-Containing Primers
inferred← citeshttps://doi.org/10.1135/cccc20011698openalex-snapshot
Interactions of 1-[(S)-3-Hydroxy-2-(phosphonomethoxy)propyl]cytosine (Cidofovir) Diphosphate with DNA Polymerases α, δ and ε*
inferred← citeshttps://doi.org/10.1159/000053979openalex-snapshot
Inhibition of Cytomegalovirus in vitro and in vivo by the Experimental Immunosuppressive Agent Leflunomide
inferred← citeshttps://doi.org/10.1159/000061700openalex-snapshot
Antiviral Agents That Are Active against CMV: Potential of Cidofovir for the Treatment of CMV and Other Virus Infections
inferred← citeshttps://doi.org/10.1177/135965350701200608openalex-snapshot
Different Mutations in the HHV-6 DNA Polymerase Gene Accounting for Resistance to Foscarnet
inferred← citeshttps://doi.org/10.1186/1860-5397-3-40openalex-snapshot
N-1 regioselective Michael-type addition of 5-substituted uracils to (2-hydroxyethyl) acrylate
inferred← citeshttps://doi.org/10.1517/13543776.10.2.165openalex-snapshot
Novel agents for the treatment of human cytomegalovirus infection
inferred← citeshttps://doi.org/10.1517/13543776.11.1.1openalex-snapshot
Gene therapy for cystic fibrosis
inferred← citeshttps://doi.org/10.1517/14728214.2011.591786openalex-snapshot
Emerging drugs for varicella-zoster virus infections
inferred← citeshttps://doi.org/10.1517/17460441.2.9.1263openalex-snapshot
The design and development of drugs acting against the smallpox virus
inferred← citeshttps://doi.org/10.1586/14787210.1.1.21openalex-snapshot
Potential of acyclic nucleoside phosphonates in the treatment of DNA virus and retrovirus infections
inferred← citeshttps://doi.org/10.20944/preprints202012.0281.v1openalex-snapshot
A COVID-19 Drug Repurposing Strategy Through Quantitative Homological Similarities by using a Topological Data Analysis Based Formalism
inferred← citeshttps://doi.org/10.2165/00003495-199958020-00015openalex-snapshot
Cidofovir
inferred← citeshttps://doi.org/10.2165/00003495-200969020-00002openalex-snapshot
Antimicrobial Strategies
inferred← citeshttps://doi.org/10.2165/11316080-000000000-00000openalex-snapshot
Antivirals for Cytomegalovirus Infection in Neonates and Infants
inferred← citeshttps://doi.org/10.2174/1385272826666220112152330openalex-snapshot
Recent Developments in the Synthesis of Bicyclic Condensed Pyrimidinones
inferred← citeshttps://doi.org/10.2460/ajvr.2005.66.217openalex-snapshot
Effects of cidofovir on cell death and replication of feline herpesvirus-1 in cultured feline corneal epithelial cells
inferred← citeshttps://doi.org/10.3390/idr16010005openalex-snapshot
Management of Cytomegalovirus Infections in the Era of the Novel Antiviral Players, Letermovir and Maribavir
inferred← citeshttps://doi.org/10.3390/microorganisms6030073openalex-snapshot
Antiviral Compounds from Myxobacteria
inferred← citeshttps://doi.org/10.3390/pathogens12111352openalex-snapshot
Mapping the Landscape of Health Research Priorities for Effective Pandemic Preparedness in Human Mpox Virus Disease
inferred← citeshttps://doi.org/10.3390/ph17050661openalex-snapshot
Small Molecule Drugs Targeting Viral Polymerases
inferred← citeshttps://doi.org/10.3390/v11030219openalex-snapshot
Terminase Large Subunit Provides a New Drug Target for Herpesvirus Treatment
inferred← citeshttps://doi.org/10.3390/v13050817openalex-snapshot
HCMV Antivirals and Strategies to Target the Latent Reservoir
inferred← citeshttps://doi.org/10.3390/v13071228openalex-snapshot
Current Drugs to Treat Infections with Herpes Simplex Viruses-1 and -2
inferred← citeshttps://doi.org/10.3390/v14102155openalex-snapshot
Monkeypox: A Comprehensive Review
inferred← citeshttps://doi.org/10.3390/v2122740openalex-snapshot
Development of CMX001 for the Treatment of Poxvirus Infections
inferred← citeshttps://doi.org/10.3390/v2122803openalex-snapshot
Cidofovir Activity against Poxvirus Infections
inferred← citeshttps://doi.org/10.36233/0507-4088-336openalex-snapshot
Antiviral potential of combinations of etiotropic antiherpetic agents including LAS-131, a novel terminase complex inhibitor, to affect the reproduction of herpes simplex virus type 1 (Orthoherpesviridae: Simplexvirus: Simplexvirus humanalpha1)
inferred← citeshttps://doi.org/10.4155/fmc-2018-0324openalex-snapshot
Alpha-Carboxynucleoside Phosphonates: Direct-Acting Inhibitors of Viral DNA Polymerases
inferred← citeshttps://doi.org/10.4172/2254-609x.100073openalex-snapshot
Prevalence of Human Cytomegalovirus Infection among Human Immunodeficiency Virus Positive Women Receiving Antiretroviral Treatment at Federal Teaching Hospital Abakaliki, Ebonyi State, Nigeria
inferred← citeshttps://doi.org/10.5525/gla.thesis.432openalex-snapshot
Analysis of two hypervariable human cytomegalovirus genes, UL146 and UL139
inferred← citeshttps://doi.org/10.70675/9297b9f7z64fdz45e2z9d6fzd046830c540copenalex-snapshot
Cibles thérapeutiques des infections à adénovirus humains
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.